Navigation Links
Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinson's Treatment
Date:1/25/2013

NEW BRUNSWICK, N.J., Jan. 25, 2013 /PRNewswire-USNewswire/ -- Parkinson's disease affects one million people in the United States and seven million worldwide. While L-Dopa is effective in treating the disease symptoms, the vast majority of patients taking it chronically eventually develop L-Dopa Induced Dyskinesia (LID), abnormal involuntary movements that can be disabling.

A new company, MentiNova, Inc., is exploring an oral medication that could reduce these uncontrollable, often chaotic movements in patients being treated with L-Dopa.  Foundation Venture Capital Group (FVCG), a New Jersey Health Foundation affiliate, has committed up to $500,000 to advance this research and development. 

According to James M. Golubieski , president of FVCG, the investment in MentiNova will allow the company to advance the status of its IND (Investigational New Drug) filing with the FDA and to perform clinical trials testing the efficacy of the treatment.

Dr. M. Maral Mouradian , the William Dow Lovett Professor of Neurology and Director of the Center for Neurodegenerative and Neuroimmunologic Diseases at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School in Piscataway, NJ, is a co-founder of the company.

Dr. Mouradian said MentiNova's focus at this time is to use a drug that is currently clinically approved and repurpose it for the treatment of LID in patients with Parkinson's disease.

"Once we can prove positive results for using this medication for patients with Parkinson's disease suffering from L-Dopa Induced Dyskinesia, we hope to be able to test it for expanded usage in patients with other conditions that are characterized by involuntary movements such as Tourette's syndrome, Huntington's disease and Tardive Dyskinesia," said Dr. Mouradian.

Res
'/>"/>

SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asthma and Allergy Foundation of America Challenges Patients and Caregivers to Get Smart About Asthma
2. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
3. UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community
4. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
5. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
6. USANA True Health Foundation: Musician Donates Proceeds Of Holiday Song To Charity
7. Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
8. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
9. The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
10. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
11. National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... in New York on Wednesday, December ... Dr. Helen Torley , President and Chief Executive Officer, ... be webcast through the "Investors" section of Halozyme,s corporate website ... available for 90 days following the event. To access the ...
(Date:11/26/2014)... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number of directly operated stores, ... quarter ended September 30, 2014. Financial HighlightsFor the ... increased by 8.1% compared to the third quarter of ... million (US$120.3 million) compared to RMB683.2 million in the third ...
(Date:11/24/2014)... 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... overview and update at the Piper Jaffray 26 th ... a.m. Eastern Time (5:30 a.m. Pacific Time), at The New ... A live audio webcast of the presentation will ... at www.arenapharm.com . A replay of the presentation will ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3
... LOS ALTOS, Calif. , Feb. 8 InteKrin ... Board Chairman, Christos Mantzoros , M.D., DSc., FACP, FACE, has ... and Professor in Environmental Health at the Harvard School of ... Harvard ,s Division of Endocrinology, Diabetes, and Metabolism, and is an ...
... , FilterPure Director to Shave Head ... VALLEY, Ariz. , Feb. 6 FilterPure and ... ground breaking ceremony in Port-Au-Prince, Haiti for a ... to build, manufacture and distribute the FilterPure filters that eliminate ...
Cached Medicine Technology:InteKrin Therapeutics' Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School 2Groundbreaking Ceremony in Port-au-Prince, Haiti for FilterPure Water Filtration Factory 2
(Date:11/26/2014)... Pharmaceutical and biotech companies require precise control ... and research activities, a task in which HVAC ... key role. Changes in temperature can promote the ... affect the quality of drugs and also support ... to address these problems and keeps the product ...
(Date:11/26/2014)... Deaf teens have stronger language and reading skills if their ... study suggests. Researchers looked at a group of deaf ... through an infant screening program conducted in the 1990s. ... those who were screened by the time they were 9 ... children who weren,t screened as infants. This new study ...
(Date:11/26/2014)... HealthDay Reporter WEDNESDAY, Nov. ... their dogs understand what they,re saying, a new study suggests ... a human-like way. Past research has shown that dogs ... actual content and the emotional tone, said study author Victoria ... into the canine brain, according to Ratcliffe, a Ph.D. candidate ...
(Date:11/26/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 (HealthDay ... health officials said. In fact, the rate of cigarette ... 18 percent in 2013. That means the number of cigarette ... increasing population, according to the U.S. Centers for Disease Control ... way to go, and if we don,t bend the curve ...
(Date:11/26/2014)... 2014 The Maryland Economic Development ... tenth annual MEDA Awards, which, sponsored by Miles ... Maryland. “The MEDA Awards recognize the individuals, programs ... state. We encourage our members to nominate the ... positive economic impact in the state of Maryland,” ...
Breaking Medicine News(10 mins):Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 5Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 2Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 3Health News:Maryland Economic Development Association Seeking Submissions for 2015 Awards 2
... , PRINCETON, N.J., Sept. 9 NephroGenex, Inc., ... announced the completion of patient enrollment in its Phase 2b clinical ... candidate Pyridorin(TM) (pyridoxamine dihydrochloride ) in type 2 diabetic patients ... have been randomized. , , The ...
... , , , ... -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) ... Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in ... available in the United States for the treatment of pain and ...
... ... provide comprehensive security solution which includes PHARMORX,s new iPhone application for authentication and ... and diversion of products, within the pharmaceutical, food and beverage, cosmetic and consumer ... ...
... , , , ... 9 Research shows that 80 percent of cardiac events in women could ... exercise and abstinence from smoking. That,s why the American Heart Association,s Go Red ... yet life-saving - choices for their hearts in a new 30-minute NBC television ...
... PRINCETON, N.J., Sept. 9 Covance Inc. (NYSE: ... Weisel Partners 2009 Healthcare Conference on Thursday, September 10, 2009 at ... the presentation at www.covance.com . In order ... minutes early. , , Covance, with headquarters in ...
... , MURRIETA, Calif., Sept. 9 ... division provides drug and alcohol rehabilitation and a variety of ... announced today that Jerrod Menz, Forterus Vice President and co-founder ... Fent, Executive Vice President, will be interviewed on the VoiceAmerica ...
Cached Medicine News:Health News:NephroGenex Announces Full Enrollment in New Pyridorin(TM) Clinical Trial - PYR 210 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 2Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 3Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 4Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 5Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 6Health News:Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever 7Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 2Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 3Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 4Health News:Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution 5Health News:Go Red For Women and NBC Team Up to Help Women 'Choose to Live' 2Health News:Go Red For Women and NBC Team Up to Help Women 'Choose to Live' 3Health News:Go Red For Women and NBC Team Up to Help Women 'Choose to Live' 4Health News:Go Red For Women and NBC Team Up to Help Women 'Choose to Live' 5Health News:Forterus Inc. Executives to Be Interviewed on VoiceAmerica 2
... The Urodynamics Chair allows easy ... to the table, it can be ... either direction. The chair has a ... positioning of the flowmeter or other ...
Biosite continues its tradition of leadership and innovation with the development of the Triage TOX Drug Screen. This breakthrough technology sets new standards for clear, convenient and controlled,...
... technique utilises a generic PCR amplification with ... region of an HLA locus. This is ... to an array of Sequence Specific Oligonucleotide ... immobilisation of these probes is referred to ...
... The Reichert UNISTAT ... photometric analyzer for determining ... newborn infants. It quickly ... tests are needed by ...
Medicine Products: